- D19A0005 Selective Topo-IIa Chemotherapeutics
- D19A0004 Universal Antibody Lock to Enhance Antibody Drug Selectivity and Safety
- D19A0003 Development of WYC-0209-241 as GSTO Inhibitor for Cancer Therapy
- D18A0010 Development of Dengue Vaccine without ADE Risk
- D18A0008 A Needle Electrode for Electroporation
- D18A0007 A Novel Drug MJ-66 for Treatment of Brain Cancer
- D18A0005 Quantity and Quality Controlled Bioprocess of Chimeric Antigen Receptor (CAR)-T Cells and Integrated Continuous Bioprocessing Platform
- D18A0004 Novel GABAAR-a6 Subtype-selective Ligands for Neuropsychiatric disorders
- D18A0003 Point-of-Care Diagnostic Assays Using Novel Electrical Microfluidic Chips
- D18A0002 A Novel Bispecific Antibody and a Method for One-step Differentiating, Expanding, and Arming T Cells
DCC
Banner
